Efg Asset Management (North America) Corp. Crispr Therapeutics Ag Transaction History

Efg Asset Management (North America) Corp.

$566 Million
Q2 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$60.67 - $89.12 $3.97 Million - $5.83 Million	-65,422 Reduced 88.08%	8,856 $603,000
Q4 2023 Feb 08, 2024	SELL	$38.62 - $72.18 $324,176 - $605,878	-8,394 Reduced 10.15%	74,278 $4.65 Million
Q3 2023 Nov 02, 2023	BUY	$45.39 - $59.0 $348,912 - $453,533	7,687 Added 10.25%	82,672 $3.75 Million
Q2 2023 Jul 28, 2023	SELL	$43.47 - $67.77 $875,007 - $1.36 Million	-20,129 Reduced 21.16%	74,985 $4.21 Million
Q1 2023 Apr 27, 2023	BUY	$41.0 - $56.12 $31,447 - $43,044	767 Added 0.81%	95,114 $4.3 Million
Q4 2022 Feb 03, 2023	BUY	$39.19 - $65.67 $391,547 - $656,108	9,991 Added 11.84%	94,347 $3.84 Million
Q3 2022 Oct 28, 2022	BUY	$61.1 - $83.78 $272,261 - $373,323	4,456 Added 5.58%	84,356 $5.52 Million
Q2 2022 Aug 04, 2022	BUY	$43.23 - $73.83 $166,003 - $283,507	3,840 Added 5.05%	79,900 $4.86 Million
Q1 2022 Apr 26, 2022	BUY	$53.19 - $79.24 $4.05 Million - $6.03 Million	76,060 New	76,060 $4.78 Million

Others Institutions Holding CRSP

# of Institutions

523

Shares Held

58M

Call Options Held

1.73M

Put Options Held

1.84M

Capital International Investors Los Angeles, CA

7.87M
Shares

$370 Million
0.09% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.78M
Shares

$366 Million
3.82% of portfolio
Nikko Asset Management Americas, Inc.

3.15M
Shares

$148 Million
1.99% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

3.15M
Shares

$148 Million
0.13% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$131 Million
0.0% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.67B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Account